Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Unlike conventional treatments like NSAIDs (which reduce pain temporarily) or corticosteroid injections (which can weaken tissue over time), BPC-157 actually promotes regeneration of damaged tissues
Meanwhile, average annual treatment costs for oncology and rare diseases [are] both approaching $300,000 per patient. A SEQUEL TO BIG PHARMAS PRICE-GOUGING ON DIABETES DRUGS GLP-1s grew out of a category of medicines originally designed for treating diabetes
And the customer knowingly accepts these risks
designed for research use only Stacking With Other Products: Frequently researched alongside TB 500 for enhanced tissue regeneration May be combined with GHK-Cu to support collagen synthesis and skin repair Studied with CJC-1295 or Ipamorelin in regenerative protocols Avoid stacking with unregulated experimental compounds outside controlled settings Side Effects: Mild injection-site redness or irritation Rare transient nausea Temporary headaches Limited long-term human safety data available Contraindications: Pregnancy or breastfeeding Active malignancy due to angiogenic activity Known hypersensitivity to peptide components Severe uncontrolled cardiovascular conditions Conclusion Dragon Pharma BPC 157 is a research-focused regenerative peptide widely studied for its effects on tissue healing, angiogenesis, and cytoprotection
References Dennis A, Wamil M, Alberts J, Oben J, Cuthbertson DJ, Wootton D, et al
Together, they help promote a leaner physique while supporting energy levels and overall performance
US$ 23.58
US$ 29.61
US$ 22.53
